Thus, in ABC-DLBCL, the ROCK2-IRF4 pathway modulates the expression of a subset of IRF4 target genes, which primarily encompasses genes that are repressed by IRF4. The gene discussed is ROCK2; the disease is diffuse large B-cell lymphoma.